Atlas Trials

A Phase 2 Safety, Tolerability, PK, and Efficacy Study of CS-1103 Following Fentanyl Challenge With Naloxone Blockade

Clinical trial NCT07459166 · RECRUITING

Trial details

NCT number
NCT07459166
Sponsor
Clear Scientific, Inc.
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Fentanyl OverdoseFentanyl Poisoning
Start date
2026-05-28
Primary completion
2026-07-01
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.